Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Lower lung donor PaO2/FiO2 ratio correlates with early primary graft dysfunction, but does not impact overall survival after lung transplantation: a dual center study.

Created on 24 Oct 2026

Authors

Rene Novysedlak, Cedric Vanluyten, Jan Van Slambrouck, Annalisa Barbarossa, Hanne Beeckmans, Dirk Van Raemdonck, Paul De Leyn, Hans Van Veer, Lieven Depypere, Yanina Jansen, Bart M Vanaudenaerde, Robin Vos, Ann Belmans, Andrea Zajacova, Monika Svorcova, Jaromir Vajter, Janis Tavandzis, Jiri Pozniak, Jan Simonek, Zuzana Ozaniak Strizova, Jiri Vachtenheim, Robert Lischke, Laurens J Ceulemans

Published in

Transplant international : official journal of the European Society for Organ Transplantation. Volume 39. Pages 16414. Epub Oct 09, 2026.

Abstract

Extended criteria donor lungs falling below the arbitrarily set PaO2/FiO2 (PFR) threshold of 300 are frequently declined despite other acceptable parameters. This two-center retrospective analysis investigates whether donor PFR is a risk factor for outcomes after lung transplantation (LuTx). A retrospective cohort analysis was conducted at University Hospitals Leuven, Belgium and Motol University Hospital, Prague, Czech Republic including adult LuTx recipients from 2010 to 2022 (Leuven) and 2018-3/2023 (Prague). Primary endpoints: primary graft dysfunction (PGD) grade 3 at 24 and 72 h and 2-year overall survival. Secondary endpoints: incidence of ACR and CLAD-free survival. Donor PFR was measured from an arterial blood gas sample. Logistic and Cox regression analyses were employed to assess correlations, while survival was analyzed using Kaplan-Meier estimates. A total of 984 LuTx recipients were included. Median follow-up was 4 years. Recipients were predominantly male (54%), with chronic obstructive pulmonary disease being the most common indication for transplantation. Donor characteristics included median age of 51 years, and 18% of donors were DCD. Analyses identified lower donor PFR as a risk factor for PGD grade 3 at 24 h, but not at 72 h. PFR was not associated with the incidence of ACR or with 2-year overall survival after LuTx. Donor PFR does not appear to be a risk factor for development of late PGD or for adversely impacting outcomes. However, it is associated with increased risk of early PGD.

PMID:
42920666
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 20
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement